Current developments in antibiotic discovery
EMBO Reports · 09.01.2023 · 24 (1)
DOI: 10.15252/embr.202256184 ↗Kurz gefasst
Fachartikel in der Zeitschrift EMBO Reports, online erschienen am 21.12.2022. Verfasst von Julian D Hegemann und 3 weiteren Autor:innen. Beteiligte Einrichtung: Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Biological Evolution. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
In light of the pending antibiotic resistance crisis, we need to go back to nature and search for novel anti-bacterial compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany.
- Department of Pharmacy, Saarland University, Saarbrücken, Germany.
- Helmholtz International Lab for Anti-Infectives, Saarbrücken, Germany.
ORCID-Profile: Julian D Hegemann, Joy Birkelbach, Sebastian Walesch, Rolf Müller
Zitieren
APA
Hegemann, J. D., Birkelbach, J., Walesch, S., & Müller, R. (2023). Current developments in antibiotic discovery. EMBO Reports, 24(1). https://doi.org/10.15252/embr.202256184
Vancouver
Hegemann JD, Birkelbach J, Walesch S, Müller R. Current developments in antibiotic discovery. EMBO Reports. 2023;24(1). doi:10.15252/embr.202256184
BibTeX
@article{Hegemann2023,
author = {Hegemann, Julian D and Birkelbach, Joy and Walesch, Sebastian and Müller, Rolf},
title = {Current developments in antibiotic discovery},
journal = {EMBO Reports},
year = {2023},
volume = {24},
number = {1},
doi = {10.15252/embr.202256184}
}
EUVIMED